Pharmacy-led pilot ADR monitoring scheme underway
A postmarketing safety programme for generic ticlopidine is being considered by the US FDA,
European package inserts focus on adverse effects
The US FDA has requested proposals for an active postmarketing surveillance hospital pilot programme
Human error is a prominent cause of AEs
An increase in the number of 'Dear Healthcare Professional' letters regarding adverse events
More education needed about drug therapy during pregnancy
Computers identify patients at risk for drug related problems
Antioxidants such as acetylcysteine may be useful for reducing cyclosporin nephrotoxicity,
NSAID-induced anaphylactic reactions are associated with HLA-DRB1 genes
Bovine colostrum may reduce NSAID-induced gut injury
Melatonin protects against cyclosporin-induced nephrototoxicity in rats,
Bezafibrate may be beneficial in patients with tamoxifen-induced non-alcoholic steatohepatitis
Riluzole may be useful for the treatment of levodopa-induced dyskinesias
HR variability may predict anthracycline cardiotoxicity
Nicorandil not associated with increased incidence of diabetes
No increased cancer risk with verapamil
Increased mortality in young children taking nitrazepam
Ibuprofen may be linked with necrotising fasciitis in children
Hypoprothrombinaemia risk increased with cefoperazone
No tumours were detected in infants who were exposed in utero or neonatally to zidovudine
OC use increases risk of gestational trophoblastic tumours
Alcuronium chloride/rocuronium bromide
Atorvastatin
Acenocoumarol interaction
Baclofen
Cyclosporin
Dipyrone
Desflurane/suxamethonium chloride
Clarithromycin
Furosemide
Fluvastatin
Fluoxetine/paroxetine
Indinavir
Lidocaine
Interferon-α-2b
Pentamidine
Olanzapine
Propofol
Tramadol
Quetiapine
Theophylline interaction